Physician profile
Thomas Serena
NPI 1174020382
$8,311.24
in general payments reported to CMS, 2019-2025
27 companies · $3,915 in 2025
The $3,915 reported for 2025 was more than what 82% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $183 · 2021: $188 · 2022: $742 · 2023: $1,836 · 2024: $1,026 · 2025: $3,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,096 · Grant: $1,394 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,095.55 |
| Grant | $1,393.76 |
| Travel and Lodging | $288.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,232.80 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Cook Incorporated | $1,393.76 | 2023 | |
| W. L. Gore & Associates, INC. | $936.02 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Silk Road Medical, INC. | $316.47 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Integra Lifesciences Corporation | $310.28 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baudax Bio INC. | $227.50 | 2022 | |
| Bard Peripheral Vascular, INC. | $218.65 | 2022-2023 | Fluency Endovascular Stent Graft |
| Polarityte, INC. | $188.58 | 2019 | |
| Tela Bio, INC. | $165.53 | 2019-2022 | |
| Endologix LLC | $157.40 | 2020 | |
| Stryker Corporation | $156.62 | 2025 | Artix Mt |
| Penumbra, INC. | $149.39 | 2025 | Indigo System |
| Osiris Therapeutics INC. | $123.25 | 2019 | |
| Philips North America LLC | $122.36 | 2024 | (Br5) Peripheral Ivus, (Bz1) Tack Endovascular Systems Btk, (4066) Tack Endovascular Systems Atk |
| Cook Medical LLC | $116.62 | 2025 | Zenith, Zenith Spiral-Z |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $109.64 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Organogenesis INC. | $71.34 | 2022 | |
| Medical Device Business Services, INC. | $70.62 | 2019 | |
| Boston Scientific Corporation | $63.40 | 2024 | Ekosonic |
| Shockwave Medical, INC | $35.64 | 2025 | |
| Terumo Medical Corporation | $27.03 | 2025 | Tr Band, Angio-Seal |
| La Jolla Pharmaceutical Company | $25.30 | 2020 | |
| Csl Behring | $21.86 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $19.80 | 2019 | |
| Hologic Sales and Service, LLC | $18.92 | 2023 | Coolseal Generator |
| Lemaitre Vascular, INC. | $18.28 | 2025 | Artegraft Vascular Graft |
| Shape Memory Medical INC. | $14.18 | 2025 | Impede Embolization Plug |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Serena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.